Takeda Pharmaceutical Co. Ltd. - Cash Flows Other Operating

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Cash-Flows-Other-Operating" stands at 21.55 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2023.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of 74.01 Billion JPY for the item "Cash Flows Other Operating" represents an increase of 547.69 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of 74.01 Billion JPY for the item "Cash Flows Other Operating" represents an increase of 443.36 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 21.55 Billion JPY for the item "Cash Flows Other Operating" represents an increase of 129.12 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 95.38 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 95.38 Billion Japanese Yens.
The 3 year change is 73.29 Billion Japanese Yens.
The 5 year change is 47.27 Billion Japanese Yens.
The 10 year change is 170.41 Billion Japanese Yens.

The Serie's long term average value is -52.26 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 73.81 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 03/31/2015, to it's latest available value, on 09/30/2025, is +170.41 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 06/30/2023, to it's latest available value, on 09/30/2025, is -11.82 Billion.